> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Opioid REMS Education Program
- URL: https://www.fdaweb.com/workshop-on-opioid-rems-education-program/
- Published: 2020-11-05T12:00:00.000Z
- Updated: 2026-09-14T16:35:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148028

*Federal Register* notice: FDA has announced a 12/11 public workshop entitled “Evaluating the Effect of the Opioid Analgesics Risk Evaluation and Mitigation Strategy Education Program on Prescribing Behaviors and Patient Outcomes — Exploring the Path Forward for Assessment.” Its purpose is to obtain scientific input on methods to evaluate the Opioid Analgesics Risk Evaluation and Mitigation Strategy education program. To assist in the workshop discussion, FDA is making available an issues paper that provides a brief overview of the REMS background and challenges with evaluating the REMS education intervention. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-11-05/pdf/2020-24542.pdf?ref=fdaweb.com).